drugset / Trial / NCT00022113

EMD 121974 in Treating Patients With Advanced Solid Tumors

NCT00022113

Phase 1 Completed 35 enrolled National Cancer Institute (NCI)
NaSingle-groupOpen-labelTreatment

Summary

Phase I trial to study the effectiveness of EMD 121974 in treating patients who have advanced solid tumors. EMD 121974 may slow the growth of solid tumors by stopping blood flow to the tumor

Timeline

Start
2001-05
Primary completion
2005-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject cilengitide Peptide Intravenous